Search

everythinglearnresearchcommunity

for

Search:↓

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

A woman with lupus had right heart failure due to blood clots in her lungs, but treatment improved her condition.

Cocaine possibly mixed with levamisole caused a woman's skin condition and blood issues, which improved with treatment.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Bridging anticoagulation may raise post-surgery bleeding risks.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

The document says that there are treatments for hair and nail diseases.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.